LibbyPBuringJEBadimonL, et al.Atherosclerosis. Nat Rev Dis Primers2019; 5: 56–56.
2.
FukumotoYLibbyPRabkinE, et al.Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation2001; 103: 993–999.
3.
PasterkampGden RuijterHMLibbyP. Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease. Nat Rev Cardiol2017; 14: 21–29.
4.
TaguchiIIimuroSIwataH, et al.High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): A randomized superiority trial. Circulation2018; 137: 1997–2009.
5.
KinoshitaMYokoteKAraiH, et al.Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb2018; 25: 846–984.
6.
Sigvant B, Hasvold P, Thuresson M, et al. Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women. Results from a Swedish nationwide study. Eur J Prev Cardiol. Epub ahead of print 16 December 2019. DOI: 10.1177/2047487319893046.
7.
NakayoshiTUenoTSasakiKI, et al.Differential angioscopic findings of neointimal coverage among first-, second-, and next generation drug-eluting stents. Int J Cardiol2016; 223: 450–451.
8.
KrawiszAKSecemskyEA. Paclitaxel-based devices for the treatment of PAD: Balancing clinical efficacy with possible risk. Curr Treat Options Cardiovasc Med2019; 21: 57–57.
9.
Sakaue A, Adachi H, Enomoto M, et al. Association between physical activity, occupational sitting time and mortality in a general population: An 18-year prospective survey in Tanushimaru, Japan. Eur J Prev Cardiol. Epub ahead of print 5 November 2018. DOI:10.1177/2047487318810020.